Aragen Life Sciences & FAR Biotech to advance preclinical programme in neurodegeneration
Aragen Life Sciences & FAR Biotech to advance preclinical programme in neurodegeneration
Source: biospectrumindia.com
Stay updated with breaking news from Simon Haydar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aragen Life Sciences & FAR Biotech to advance preclinical programme in neurodegeneration
/PRNewswire/ -- Aragen Life Sciences (Aragen), a leading Contract Research and Development Organization (CRO), and FAR Biotech (FAR), a US-based, AI-driven,...
Toronto, ON (PRWEB) June 15, 2022 -- Covalent drugs could provide pharmacological advantages like prolonged duration of action and enhanced potency over